MARKET

RGEN

RGEN

Repligen
NASDAQ
175.42
+2.91
+1.69%
After Hours: 175.42 0 0.00% 16:04 10/13 EDT
OPEN
172.51
PREV CLOSE
172.51
HIGH
177.96
LOW
169.73
VOLUME
1.26M
TURNOVER
--
52 WEEK HIGH
198.87
52 WEEK LOW
100.99
MARKET CAP
9.90B
P/E (TTM)
239.09
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at RGEN last week (1005-1009)?
Weekly Report · 1d ago
Does Repligen (RGEN) Look Fully Valued After The BioLife Deal?
Simply Wall St · 1d ago
These healthcare stocks have the highest EPS revision grade ahead of Q3 results
Seeking Alpha · 4d ago
Private Markets: Varda Space, GMI headline week’s startup fundraising
TipRanks · 5d ago
Repligen Is Maintained at Overweight by Barclays
Dow Jones · 6d ago
Barclays Maintains Overweight on Repligen, Raises Price Target to $225
Benzinga · 6d ago
Repligen price target raised to $225 from $175 at Barclays
TipRanks · 6d ago
Repligen Corp Completes Acquisition Of BioLife Solutions
NASDAQ · 6d ago
More
About RGEN
Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its franchises include filtration, chromatography, process analytics and proteins. Its filtration franchise includes product offering covering upstream and downstream technologies. Its filtration products include XCell Alternating Tangential Flow (ATF) Cell Retention Systems, Flat Sheet Cassettes, Hollow Fiber Consumables, Tangential Flow Filtration Systems and Fluid Management. Its chromatography franchise includes products used in downstream purification, development, manufacturing and quality control of biological drugs. Its chromatography franchise includes OPUS Pre-Packed Columns, KRM Chromatography Systems and other additional chromatography products. Its process analytics include Downstream process analytical technology (PAT) and Upstream PAT. Its Proteins include Protein A Affinity Ligands, AVIPure Resins for New Modalities and Growth Factors.

Webull offers Repligen Corp stock information, including NASDAQ: RGEN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RGEN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RGEN stock methods without spending real money on the virtual paper trading platform.